| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 3, Issue 8 507-513, Copyright © 1992 by American Association of Cancer Research
ARTICLES |
GL Prasad, EM Valverius, E McDuffie and HL Cooper
Cell and Molecular Physiology Section, National Cancer Institute, Bethesda, Maryland 20892.
A full-length complementary DNA clone from a normal human mammary epithelial cell (strain 184) encoding a 25-kilodalton protein, HME1, was isolated. Expression of HME1 RNA appears to be limited to epithelial cells. The HME1 sequence has extensive sequence homology with bovine 14-3-3 protein, which is an activator of tyrosine and tryptophan hydroxylase. However, the tissue distribution, arrangement of charged amino acids, and location of potential phosphorylation sites of HME1 differ from those of 14-3-3. Compared with normal mammary epithelial cells, expression of HME1 RNA was dramatically low in two cell lines derived from human mammary carcinoma that were examined, and in a line of normal mammary epithelial cells transformed by oncogenes. HME1 therefore appears to be a cellular differentiation marker that may be down-regulated during neoplastic transformation.
This article has been cited by other articles:
 |
|
 |
|
  A.-L. Cheng, W.-G. Huang, Z.-C. Chen, F. Peng, P.-F. Zhang, M.-Y. Li, F. Li, J.-L. Li, C. Li, H. Yi, et al. Identification of Novel Nasopharyngeal Carcinoma Biomarkers by Laser Capture Microdissection and Proteomic Analysis Clin. Cancer Res., January 15, 2008; 14(2): 435 - 445. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. J. Godde, G. M. D'Abaco, L. Paradiso, and U. Novak Efficient ADAM22 surface expression is mediated by phosphorylation-dependent interaction with 14-3-3 protein family members J. Cell Sci., August 15, 2006; 119(16): 3296 - 3305. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Han, H. Xie, Q. Chen, and J.-T. Zhang Sensitizing hormone-refractory prostate cancer cells to drug treatment by targeting 14-3-3{sigma}. Mol. Cancer Ther., April 1, 2006; 5(4): 903 - 912. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Yang, Y.-Y. Wen, R. Zhao, Y.-L. Lin, K. Fournier, H.-Y. Yang, Y. Qiu, J. Diaz, C. Laronga, and M.-H. Lee DNA Damage-Induced Protein 14-3-3 {sigma} Inhibits Protein Kinase B/Akt Activation and Suppresses Akt-Activated Cancer. Cancer Res., March 15, 2006; 66(6): 3096 - 3105. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Liu, H. Liu, B. Han, and J.-T. Zhang Identification of 14-3-3{sigma} as a Contributor to Drug Resistance in Human Breast Cancer Cells Using Functional Proteomic Analysis. Cancer Res., March 15, 2006; 66(6): 3248 - 3255. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Yang, R. Zhao, and M.-H. Lee 14-3-3{sigma}, a p53 regulator, suppresses tumor growth of nasopharyngeal carcinoma. Mol. Cancer Ther., February 1, 2006; 5(2): 253 - 260. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. A. Moreira, G. Ohlsson, F. E. Rank, and J. E. Celis Down-regulation of the Tumor Suppressor Protein 14-3-3{sigma} Is a Sporadic Event in Cancer of the Breast Mol. Cell. Proteomics, April 1, 2005; 4(4): 555 - 569. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Guweidhi, J. Kleeff, N. Giese, J. E. Fitori, K. Ketterer, T. Giese, M. W. Buchler, M. Korc, and H. Friess Enhanced expression of 14-3-3sigma in pancreatic cancer and its role in cell cycle regulation and apoptosis Carcinogenesis, September 1, 2004; 25(9): 1575 - 1585. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-i. Satoh, T. Yamamura, and K. Arima The 14-3-3 Protein {epsilon} Isoform Expressed in Reactive Astrocytes in Demyelinating Lesions of Multiple Sclerosis Binds to Vimentin and Glial Fibrillary Acidic Protein in Cultured Human Astrocytes Am. J. Pathol., August 1, 2004; 165(2): 577 - 592. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Cheng, C.-X. Pan, J.-T. Zhang, S. Zhang, M. S. Kinch, L. Li, L. A. Baldridge, C. Wade, Z. Hu, M. O. Koch, et al. Loss of 14-3-3{sigma} in Prostate Cancer and Its Precursors Clin. Cancer Res., May 1, 2004; 10(9): 3064 - 3068. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. K. Dougherty and D. K. Morrison Unlocking the code of 14-3-3 J. Cell Sci., April 15, 2004; 117(10): 1875 - 1884. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. A. Moreira, P. Gromov, and J. E. Celis Expression of the Tumor Suppressor Protein 14-3-3{sigma} Is Down-regulated in Invasive Transitional Cell Carcinomas of the Urinary Bladder Undergoing Epithelial-to-Mesenchymal Transition Mol. Cell. Proteomics, April 1, 2004; 3(4): 410 - 419. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-Y. Yang, Y.-Y. Wen, C.-H. Chen, G. Lozano, and M.-H. Lee 14-3-3{sigma} Positively Regulates p53 and Suppresses Tumor Growth Mol. Cell. Biol., October 15, 2003; 23(20): 7096 - 7107. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Sugiyama, Y. Miyagi, Y. Komiya, N. Kurabe, C. Kitanaka, N. Kato, Y. Nagashima, Y. Kuchino, and F. Tashiro Forced expression of antisense 14-3-3{beta} RNA suppresses tumor cell growth in vitro and in vivo Carcinogenesis, September 1, 2003; 24(9): 1549 - 1559. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Iacobuzio-Donahue, A. Maitra, M. Olsen, A. W. Lowe, N. T. Van Heek, C. Rosty, K. Walter, N. Sato, A. Parker, R. Ashfaq, et al. Exploration of Global Gene Expression Patterns in Pancreatic Adenocarcinoma Using cDNA Microarrays Am. J. Pathol., April 1, 2003; 162(4): 1151 - 1162. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. D. Braastad, Z. Han, and E. A. Hendrickson Constitutive DNase I Hypersensitivity of p53-Regulated Promoters J. Biol. Chem., February 28, 2003; 278(10): 8261 - 8268. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Bhatia, A. K Siraj, A. Hussain, R. Bu, and M. I Gutierrez The Tumor Suppressor Gene 14-3-3{sigma} Is Commonly Methylated in Normal and Malignant Lymphoid Cells Cancer Epidemiol. Biomarkers Prev., February 1, 2003; 12(2): 165 - 169. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Megyesi, L. Andrade, J. M. Vieira Jr., R. L. Safirstein, and P. M. Price Coordination of the cell cycle is an important determinant of the syndrome of acute renal failure Am J Physiol Renal Physiol, October 1, 2002; 283(4): F810 - F816. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Gasco, A. K. Bell, V. Heath, A. Sullivan, P. Smith, L. Hiller, I. Yulug, G. Numico, M. Merlano, P. J. Farrell, et al. Epigenetic Inactivation of 14-3-3 {sigma} in Oral Carcinoma: Association with p16INK4a Silencing and Human Papillomavirus Negativity Cancer Res., April 1, 2002; 62(7): 2072 - 2076. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Yoshikawa, M. Kusunoki, H. Yanagi, M. Noda, J.-i. Furuyama, T. Yamamura, and T. Hashimoto-Tamaoki Dual Antitumor Effects of 5-Fluorouracil on the Cell Cycle in Colorectal Carcinoma Cells: A Novel Target Mechanism Concept for Pharmacokinetic Modulating Chemotherapy Cancer Res., February 1, 2001; 61(3): 1029 - 1037. [Abstract] [Full Text]
|
|
|
|
|
|
A.-S. Vercoutter-Edouart, J. Lemoine, X. Le Bourhis, H. Louis, B. Boilly, V. Nurcombe, F. Révillion, J.-P. Peyrat, and H. Hondermarck Proteomic Analysis Reveals that 14-3-3{{sigma}} Is Down-Regulated in Human Breast Cancer Cells Cancer Res., January 1, 2001; 61(1): 76 - 80. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Takihara, Y. Matsuda, and J. Hara Role of the {beta} isoform of 14-3-3 proteins in cellular proliferation and oncogenic transformation Carcinogenesis, November 1, 2000; 21(11): 2073 - 2077. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Dhar, J. A. Squire, M. P. Hande, R. J. Wellinger, and T. K. Pandita Inactivation of 14-3-3sigma Influences Telomere Behavior and Ionizing Radiation-Induced Chromosomal Instability Mol. Cell. Biol., October 15, 2000; 20(20): 7764 - 7772. [Abstract] [Full Text]
|
|
|
|
|
|
T. M. Passalaris, J. A. Benanti, L. Gewin, T. Kiyono, and D. A. Galloway The G2 Checkpoint Is Maintained by Redundant Pathways Mol. Cell. Biol., September 1, 1999; 19(9): 5872 - 5881. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Pallas, H Fu, L. Haehnel, W Weller, R. Collier, and T. Roberts Association of polyomavirus middle tumor antigen with 14-3-3 proteins Science, July 22, 1994; 265(5171): 535 - 537. [Abstract] [PDF]
|
|
|
|
|
|
T. Samuel, H. O. Weber, P. Rauch, B. Verdoodt, J.-T. Eppel, A. McShea, H. Hermeking, and J. O. Funk The G2/M Regulator 14-3-3sigma Prevents Apoptosis through Sequestration of Bax J. Biol. Chem., November 21, 2001; 276(48): 45201 - 45206. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Laronga, H.-Y. Yang, C. Neal, and M.-H. Lee Association of the Cyclin-dependent Kinases and 14-3-3 Sigma Negatively Regulates Cell Cycle Progression J. Biol. Chem., July 21, 2000; 275(30): 23106 - 23112. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. T. Ferguson, E. Evron, C. B. Umbricht, T. K. Pandita, T. A. Chan, H. Hermeking, J. R. Marks, A. R. Lambers, P. A. Futreal, M. R. Stampfer, et al. High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer PNAS, May 23, 2000; 97(11): 6049 - 6054. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
